Whole Exome Sequencing — Nuclyra
Loading Nuclyra…
Service · Bioinformatics Pipeline

Whole Exome Sequencing

Exome-focused pipelines that concentrate sequencing depth on protein-coding regions — built for diagnostic yield and mutational analysis without the cost of a full genome.

Who this is for

TYPICAL CLIENT

A diagnostics lab that needs coding-region answers on a clinical budget

Usually a clinical genomics director or research PI running a rare disease diagnostic program or a tumor mutational-burden study, who needs deep, reliable coverage of coding regions without paying for whole-genome depth they won’t use.

What you walk away with

Six concrete deliverables, not a slide deck.

This is exactly what transfers to you at the end of this Whole Exome Sequencing engagement.

Capture-kit aware pipeline

A pipeline configured to your specific exome capture kit, so target-region coverage is optimized, not generic.

Per-target coverage QC

Coverage reported down to the individual exon, so gaps in diagnostic-relevant regions are visible before sign-off.

Variant calling & clinical annotation

GATK-based calling with variants classified against ACMG/AMP criteria to support clinical interpretation.

Trio & family analysis module

Joint calling and inheritance-pattern filtering for proband-parent trios or larger family sets.

Mutational burden & hotspot reporting

For tumor exomes, a summary of mutational burden and known hotspot variants alongside the full callset.

Full documentation & handoff session

Written documentation plus a recorded walkthrough so your team can operate the pipeline independently.

What's included

What this service includes

Capture-aware target QC

Coverage and uniformity reported against your exact capture kit’s target BED file, not a generic exome definition.

Clinical-grade variant calling

GATK and DeepVariant calling tuned for diagnostic-grade sensitivity on coding regions.

ACMG/AMP classification support

Variants pre-classified against ACMG/AMP criteria to speed up clinical review, not replace it.

Trio & family inheritance analysis

De novo, recessive and compound-heterozygous filtering built into the standard workflow.

In practice

What this looks like in a real engagement

Three concrete examples of the kind of work this service covers.

Rare disease diagnostic exome

A proband exome analyzed against phenotype-driven gene panels to identify a likely causal variant.

Tumor exome for mutational burden

Tumor-normal exome pairs processed to report somatic mutations and overall tumor mutational burden.

Carrier screening exome panel

A cohort of exomes screened against a defined gene list for recessive carrier status.

Why it matters

Why exome depth beats genome breadth for a diagnostic question.

When the clinical question lives in a gene’s coding sequence, spending your sequencing budget on genome-wide breadth is often the wrong trade. Exome sequencing lets you go deeper on the regions that matter, catching low-frequency mosaic or somatic variants a shallower whole genome might miss.

We build exome pipelines around your specific capture kit and clinical question, so the coverage you pay for is coverage you can actually use in a diagnosis.

Whole exome sequencing workflow showing exon capture, sequencing and detected variant annotation
How we deliver it

How an engagement runs

Four stages, from sample intake to delivery.

Stage 01 — Intake

Sample & capture QC

Raw reads are checked against your capture kit’s target regions before alignment begins.

Stage 02 — Align & call

Alignment & variant calling

Reads are aligned to coding regions and variants called with diagnostic-grade sensitivity.

Stage 03 — Classify

Annotation & classification

Variants are annotated and pre-classified against ACMG/AMP criteria for clinical review.

Stage 04 — Report & handoff

Report & hand off

A final report and full documentation are delivered alongside a walkthrough session.

Tooling

What we build it with

BWA-MEM2GATKVEPInterVarNextflowMultiQCPicardClinVar
An exome is only as good as the capture kit it was designed around — we build the pipeline to match, not the other way round.
Questions we get

Before you reach out

Typically 100× mean on-target coverage for diagnostic work, with higher depth available for mosaic or low-frequency variant detection.

Yes — the pipeline is configured against your kit’s target BED file, whichever vendor you use.

We provide ACMG/AMP-informed pre-classification to support your clinical reviewer, not a final sign-off — that stays with your certified team.

Let’s talk

Have exomes waiting on a diagnostic answer?

Send us your capture kit and clinical question — we’ll tell you honestly what the data can and can’t support before you commit budget.